ID: ALA5205386

Max Phase: Preclinical

Molecular Formula: C18H14O2

Molecular Weight: 262.31

Associated Items:

Representations

Canonical SMILES:  O=C1C=C(CCc2ccccc2)c2ccccc2C1=O

Standard InChI:  InChI=1S/C18H14O2/c19-17-12-14(11-10-13-6-2-1-3-7-13)15-8-4-5-9-16(15)18(17)20/h1-9,12H,10-11H2

Standard InChI Key:  GPASHFSROBWQRH-UHFFFAOYSA-N

Associated Targets(Human)

PARK7 Tbio Parkinson disease protein 7 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 262.31Molecular Weight (Monoisotopic): 262.0994AlogP: 3.47#Rotatable Bonds: 3
Polar Surface Area: 34.14Molecular Species: HBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 2HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 2Heavy Atoms: 20QED Weighted: 0.79Np Likeness Score: 0.86

References

1. Maksimovic I, Finkin-Groner E, Fukase Y, Zheng Q, Sun S, Michino M, Huggins DJ, Myers RW, David Y..  (2021)  Deglycase-activity oriented screening to identify DJ-1 inhibitors.,  12  (7.0): [PMID:34355187] [10.1039/D1MD00062D]

Source